172 related articles for article (PubMed ID: 27748759)
21. Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.
Prada CE; Jousma E; Rizvi TA; Wu J; Dunn RS; Mayes DA; Cancelas JA; Dombi E; Kim MO; West BL; Bollag G; Ratner N
Acta Neuropathol; 2013 Jan; 125(1):159-68. PubMed ID: 23099891
[TBL] [Abstract][Full Text] [Related]
22. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
Yang FC; Ingram DA; Chen S; Zhu Y; Yuan J; Li X; Yang X; Knowles S; Horn W; Li Y; Zhang S; Yang Y; Vakili ST; Yu M; Burns D; Robertson K; Hutchins G; Parada LF; Clapp DW
Cell; 2008 Oct; 135(3):437-48. PubMed ID: 18984156
[TBL] [Abstract][Full Text] [Related]
23. The role of nerve microenvironment for neurofibroma development.
Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
[TBL] [Abstract][Full Text] [Related]
24. Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line.
Perrin GQ; Fishbein L; Thomson SA; Thomas SL; Stephens K; Garbern JY; DeVries GH; Yachnis AT; Wallace MR; Muir D
J Neurosci Res; 2007 May; 85(6):1347-57. PubMed ID: 17335073
[TBL] [Abstract][Full Text] [Related]
25. The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1
Pennanen P; Peltonen S; Kallionpää RA; Peltonen J
Mol Cell Biochem; 2018 Jul; 444(1-2):27-33. PubMed ID: 29185159
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.
Na Y; Hall A; Choi K; Hu L; Rose J; Coover RA; Miller A; Hennigan RF; Dombi E; Kim MO; Subramanian S; Ratner N; Wu J
Oncogene; 2021 Feb; 40(5):951-963. PubMed ID: 33293695
[TBL] [Abstract][Full Text] [Related]
27. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.
Li K; Turner AN; Chen M; Brosius SN; Schoeb TR; Messiaen LM; Bedwell DM; Zinn KR; Anastasaki C; Gutmann DH; Korf BR; Kesterson RA
Dis Model Mech; 2016 Jul; 9(7):759-67. PubMed ID: 27482814
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
29. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
30. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.
Serra E; Rosenbaum T; Winner U; Aledo R; Ars E; Estivill X; Lenard HG; Lázaro C
Hum Mol Genet; 2000 Dec; 9(20):3055-64. PubMed ID: 11115850
[TBL] [Abstract][Full Text] [Related]
31. Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma.
Chen Z; Liu C; Patel AJ; Liao CP; Wang Y; Le LQ
Cancer Cell; 2014 Nov; 26(5):695-706. PubMed ID: 25446898
[TBL] [Abstract][Full Text] [Related]
32. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A-JAK2/STAT3 positive feedback loop.
Liu X; Wang J; Wang H; Yin G; Liu Y; Lei X; Xiang M
Cancer Lett; 2015 Jun; 362(1):45-60. PubMed ID: 25779676
[TBL] [Abstract][Full Text] [Related]
33. Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
Wu J; Dombi E; Jousma E; Scott Dunn R; Lindquist D; Schnell BM; Kim MO; Kim A; Widemann BC; Cripe TP; Ratner N
Pediatr Blood Cancer; 2012 Feb; 58(2):173-80. PubMed ID: 21319287
[TBL] [Abstract][Full Text] [Related]
34. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
35. Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.
Le LQ; Shipman T; Burns DK; Parada LF
Cell Stem Cell; 2009 May; 4(5):453-63. PubMed ID: 19427294
[TBL] [Abstract][Full Text] [Related]
36. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
Wu M; Wallace MR; Muir D
J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
[TBL] [Abstract][Full Text] [Related]
37. Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin.
Roth TM; Ramamurthy P; Muir D; Wallace MR; Zhu Y; Chang L; Barald KF
Dev Dyn; 2008 Feb; 237(2):513-24. PubMed ID: 18213578
[TBL] [Abstract][Full Text] [Related]
38. Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model.
Murakami T; Takigawa N; Ninomiya T; Ochi N; Yasugi M; Honda Y; Kubo T; Ichihara E; Hotta K; Tanimoto M; Kiura K
Lung Cancer; 2014 Jan; 83(1):30-6. PubMed ID: 24238495
[TBL] [Abstract][Full Text] [Related]
39. Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1.
Coover RA; Healy TE; Guo L; Chaney KE; Hennigan RF; Thomson CS; Aschbacher-Smith LE; Jankowski MP; Ratner N
Acta Neuropathol Commun; 2018 Nov; 6(1):127. PubMed ID: 30470263
[TBL] [Abstract][Full Text] [Related]
40. Nf1 haploinsufficiency augments angiogenesis.
Wu M; Wallace MR; Muir D
Oncogene; 2006 Apr; 25(16):2297-303. PubMed ID: 16288202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
